NIH

NIH-funded researchers have developed a promising optical biopsy powered by machine learning that could improve the early detection of endometrial cancer—the most common gynecologic cancer in the U.S. This fast, noninvasive approach may help detect precancerous lesions and early cancers. 🔗 Learn more: bit.ly/4aRNBbK

Save the date: Get an inside look at how NIH makes funding decisions 📢 Join NIH leadership on August 14 to understand how NIH's Unified Funding Strategy supports informed, transparent, and flexible funding decisions while reinforcing the importance of peer review. Register for the webinar: bit.ly/3T1AXki

Help us learn about malaria transmission. Join our study. Compensation is provided. Refer to study #001970 or call the NIH Clinical Center Office of Patient Recruitment at 866-444-1134.

Congratulations to the winners of the 2026 Eye on the Future Teen Video Contest! 🏆 Adithya Vasanth — Science in Your World Anshul Raghav — Science in Action Saasha Santosh — Science in Your Future Their videos showcase the power of curiosity, innovation, and fresh perspectives. Check out the winning entries and celebrate these young creators! Watch the videos here: bit.ly/4f6gguT

For nearly 50 years, the Belmont Report has served as the foundation for ethical human subject’s research. In a new @BaltimoreSun op-ed, Director of National Health Communications Dr. Stephanie Haridopolos reflects on the Report's enduring legacy and why its principles continue to matter today. Read the full piece here: baltimoresun.com/2026/07/09/bel…

🚀NIH is launching a first-in-human clinical trial of an experimental treatment aimed at helping people with Jansen’s disease, a rare genetic disorder that impacts bone development. The project is led by scientists from the National Institute of Dental and Craniofacial Research and reflects years of collaboration across NIH and beyond. It also exemplifies the challenges scientists face in finding treatments for rare diseases that NIH can solve. Read the full story ➡️ bit.ly/3SSiyq3.

NIH is modernizing how it makes funding decisions. The new Unified Funding Strategy keeps peer review foundational while allowing NIH to consider the full picture, including scientific merit, innovation, public health needs, and emerging research opportunities. Learn more: bit.ly/4vUFLqj

Research supported by NIH suggests that gastrointestinal symptoms are not only prevalent, but represent a biologically meaningful dimension of ME/CFS. The findings may help explain why ME/CFS affects people differently and could help in future treatment study design. Read more: bit.ly/4paRoqm

Illegally manufactured fentanyl drove a sharp rise in adolescent overdose deaths in recent years. However, new findings from the NIH-funded Monitoring the Future survey indicate that many U.S. teenagers do not view the substance as highly dangerous. Read more: linkedin.com/pulse/consider…

An NIH-led study found that people diagnosed with melanoma early in life and those with multiple melanomas are more likely to carry genetic mutations that increase their risk for other cancers. The findings suggest these individuals could benefit from genetic testing to identify their risks sooner. Learn more: bit.ly/4vQMvoW

Certain blood tests already used for people with Alzheimer’s may also help identify people in midlife who have elevated levels of Alzheimer’s-related proteins in their blood, according to an NIH-funded study. While more research is needed, these findings could help people at increased risk take steps earlier to delay Alzheimer’s symptoms. Learn more: bit.ly/44eZftF

Ready to pursue pioneering ideas outside your current research program? The NIH Director’s Pioneer Award, part of the NIH Common Fund’s High-Risk, High-Reward Research program, was designed for just that. 👉 Explore the funding opportunity and apply: bit.ly/4f9nsaP 💻 Register for the informational webinar on July 13 @ 12pm ET: bit.ly/3SrlcTF

NIH researchers have begun identifying and classifying senescent cells, a hallmark of aging, to build an atlas of these cells in the human body. This research may help us better understand how senescent cells contribute to age-related conditions and inform treatment strategies for age-related diseases. Learn more: bit.ly/4fnQ2FA

Ready to skip a postdoc? The NIH Director’s Early Independence Award, part of the NIH Common Fund’s High-Risk, High-reward research program, supports exceptional junior scientists pursuing independent research careers sooner. 👉 See if you’re eligible and apply: bit.ly/3QLxx4u 💻 Register for the informational webinar on July 13 @ 2pm ET: bit.ly/3QR1RL5

A repurposed drug may offer new hope for people living with eosinophilic gastritis (EoG), a rare GI disease with no FDA-approved treatments. A new NIH-supported clinical trial found that dupilumab improved patient health, highlighting the potential of drug repurposing to speed up treatment advances for rare diseases. Learn more: bit.ly/4vLvYCO

Your voice matters. NIH is seeking input from patients, caregivers, researchers, clinicians, and advocates on Parkinson’s disease and related conditions to help shape the National Plan to End Parkinson’s: NOT-NS-26-039: grants.nih.gov/grants/guide/n… RFI closes August 22, 2026. #Parkinsons

🔬 Discover the latest advances in hearing research with the National Institute on Deafness and Other Communication Disorders (NIDCD)’s Beyond the Lab: Understanding Communication Disorders speaker series! Join Ronna Hertzano, M.D., Ph.D., Senior Investigator and Chief of the Neurotology Branch at NIDCD, as she shares how her lab is advancing our understanding of the inner ear, its response to injury, and the search for new treatments for hearing loss. She'll also highlight efforts to promote data sharing and collaboration to accelerate discoveries across the field. 🗓️ Save the date: July 15, 2026 at 1 PM ET 🎧 Don't miss this opportunity to learn how NIH research is shaping the future of hearing health: calendar.nih.gov/event/view/496…

NIH Common Fund announces 4️⃣ new funding opportunities for NIH Director’s High-Risk, High-Reward awards supporting exceptionally creative researchers with bold, innovative, high-impact ideas. 👉 Find the opportunity that fits your research: go.nih.gov/goFfpVo

38 million Americans live with type 2 diabetes — and we still don't fully understand how people can return to health. The AI-READI program is working to change that. 4,000 participants enrolled, ahead of schedule. 🔬 aireadi.org #Bridge2AI #Diabetes #AI

As America celebrates 250 years of independence, the Trump Administration is working to restore one of our most fundamental freedoms: the freedom that comes with being healthy. This Independence Day, Take Back Your Health. Eat Real Food. Get Active. Join us in building a stronger, healthier nation. Together, let's Make America Healthy Again.